BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9230794)

  • 1. Attempt to correlate urine arsenic excretion with clinical course during melarsoprol therapy of patients with Rhodesian trypanosomiasis.
    Harrison SM; Harris RW; Bales JD
    Am J Trop Med Hyg; 1997 Jun; 56(6):632-6. PubMed ID: 9230794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronidazole and suramin combination in the treatment of arsenical refractory Rhodesian sleeping sickness--a case study.
    Foulkes JR
    Trans R Soc Trop Med Hyg; 1996; 90(4):422. PubMed ID: 8882195
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of human African trypanosomiasis.
    Pépin J; Milord F
    Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Rhodesian sleeping sickness in Kenya.
    Wellde BT; Chumo DA; Reardon MJ; Abinya A; Wanyama L; Dola S; Mbwabi D; Smith DH; Siongok TA
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():99-109. PubMed ID: 2619399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen.
    Jennings FW; Rodgers J; Bradley B; Gettinby G; Kennedy PG; Murray M
    Parasitol Int; 2002 Dec; 51(4):381-8. PubMed ID: 12421636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness.
    Kuepfer I; Schmid C; Allan M; Edielu A; Haary EP; Kakembo A; Kibona S; Blum J; Burri C
    PLoS Negl Trop Dis; 2012 Aug; 6(8):e1695. PubMed ID: 22970329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.
    Checkley AM; Pepin J; Gibson WC; Taylor MN; Jäger HR; Mabey DC
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):523-6. PubMed ID: 17270227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Melarsoprol].
    Simon F
    Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741
    [No Abstract]   [Full Text] [Related]  

  • 11. Rhodesian trypanosomiasis in a splenectomized patient.
    Malesker MA; Boken D; Ruma TA; Vuchetich PJ; Murphy PJ; Smith PW
    Am J Trop Med Hyg; 1999 Sep; 61(3):428-30. PubMed ID: 10497985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.
    Kibona SN; Matemba L; Kaboya JS; Lubega GW
    Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiographic changes in African trypanosomiasis caused by Trypanosoma brucei rhodesiense.
    Jones IG; Lowenthal MN; Buyst H
    Trans R Soc Trop Med Hyg; 1975; 69(4):388-95. PubMed ID: 1216299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of African trypanosomiasis.
    Williamson J
    Trop Dis Bull; 1976 Jul; 73(7):531-42. PubMed ID: 135387
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental infection of goats with Trypanosoma brucei ssp. and effects of treatment with suramin and Mel-B.
    Wellde BT; Reardon MJ; Chumo DA; Muriithi RM; Towett S; Mwangi J
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():161-9. PubMed ID: 2619390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya.
    Bales JD; Harrison SM; Mbwabi DL; Schecter PJ
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():111-4. PubMed ID: 2515816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo.
    Balasegaram M; Harris S; Checchi F; Ghorashian S; Hamel C; Karunakara U
    Bull World Health Organ; 2006 Oct; 84(10):783-91. PubMed ID: 17128358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma brucei and T. vivax: salicylhydroxamic acid and glycerol treatment of acute and chronically infected rats.
    van der Meer C; Versluijs-Broers JA
    Exp Parasitol; 1986 Aug; 62(1):98-113. PubMed ID: 3720904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
    Simarro PP; Asumu PN
    Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.